Vimarsana
Biggest News Aggregation in the World

Page 2 - Path Lung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Path Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Path Lung Today - Breaking & Trending Today

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results - Vimarsana News

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

Published: April 1, 2023

31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...

Source: wallstreet-online.de
Related Topics:
University Of Texas At San AntonioUnited StatesUnited KingdomHong KongAlvaro Souto PadronDavid HillMaria ZannesRossella TitoneSheila HabibJulie Anne OvertonAffinity Technologies IncLaboratory Developed TestOncoselect TherapeuticsPaycheck Protection ProgramDrug AdministrationPrecision Pathology ServicesCompany ScientificYale University School Of MedicineRespiratory ResearchAffinity TechnologieCypath LungChronic Obstructive Pulmonary DiseaseVisualized ExperimentsModified BeadsCompensation Controls
Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes - Vimarsana News

Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes

Published: December 29, 2022

BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment.

Source: pressreleasepoint.com
Related Topics:
San AntonioUnited StatesMaria ZannesPrecision Pathology ServicesLaboratory Developed TestDrug AdministrationMeet Bioaffinity TechnologiesJessica De Sa MotaBioaffinity TechnologiesCypath LungPath LungExecutive OfficersClinical ResearchClinical TrialDrug DiscoveryEuropean UnionFood And Drug AdministrationLung CancerPharmaceutical IndustryAnaplastic Lymphoma KinaseDesign Of ExperimentsTreatment Of Cancer